Literature DB >> 25756958

Proteomic analysis of human Sonic Hedgehog (SHH) medulloblastoma stem-like cells.

Maurizio Ronci1, Giuseppina Catanzaro, Luisa Pieroni, Agnese Po, Zein Mersini Besharat, Viviana Greco, Stefano Levi Mortera, Isabella Screpanti, Elisabetta Ferretti, Andrea Urbani.   

Abstract

Human medulloblastoma (MB) is a malignant brain tumor that comprises four distinct molecular subgroups including the Sonic Hedgehog (SHH)-MB group. A leading cause of the SHH subgroup is an aberrant activation of the SHH pathway, a developmental signaling that regulates postnatal development of the cerebellum by promoting the mitotic expansion of granule neural precursors (GNPs) in the external granule layer (EGL). The abnormal SHH signaling pathway drives not only SHH-MB but also its cancer stem-like cells (SLCs), which represent a fraction of the tumor cell population that maintain cancer growth and have been associated with high grade tumors. Here, we report the first proteomic analysis of human SHH-MB SLCs before and after Retinoic Acid (RA)-induced differentiation. A total of 994 nLC-MS buckets were statistically analysed returning 68 modulated proteins between SLCs and their differentiated counterparts. Heat Shock Protein 70 (Hsp70) was one of the proteins that characterized the protein profile of SLCs. By means of Ingenuity Pathway Analysis (IPA), Genomatix analysis and extending the network obtained using the differentially expressed proteins we found a correlation between Hsp70 and the NF-κB complex. A key driver of the SHH-MB group is cMET whose downstream proliferation/survival signalling is indeed via PI3K/Akt/NF-κB. We confirmed the results of the proteomic analysis by western blot, underlining that a P-p65/NF-κB activatory complex is highly expressed in SLCs. Taking together these results we define a new protein feature of SHH-MB SLCs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25756958     DOI: 10.1039/c5mb00034c

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  17 in total

Review 1.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

Review 2.  Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy.

Authors:  Alexander Kabakov; Anna Yakimova; Olga Matchuk
Journal:  Cells       Date:  2020-04-06       Impact factor: 6.600

3.  Exploring the Potential of Venom from Nasonia vitripennis as Therapeutic Agent with High-Throughput Screening Tools.

Authors:  Ellen L Danneels; Ellen M Formesyn; Dirk C de Graaf
Journal:  Toxins (Basel)       Date:  2015-06-03       Impact factor: 4.546

4.  Loss of miR-107, miR-181c and miR-29a-3p Promote Activation of Notch2 Signaling in Pediatric High-Grade Gliomas (pHGGs).

Authors:  Giuseppina Catanzaro; Claudia Sabato; Michele Russo; Alessandro Rosa; Luana Abballe; Zein Mersini Besharat; Agnese Po; Evelina Miele; Diana Bellavia; Martina Chiacchiarini; Marco Gessi; Giovanna Peruzzi; Maddalena Napolitano; Manila Antonelli; Angela Mastronuzzi; Felice Giangaspero; Franco Locatelli; Isabella Screpanti; Alessandra Vacca; Elisabetta Ferretti
Journal:  Int J Mol Sci       Date:  2017-12-17       Impact factor: 5.923

5.  Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma.

Authors:  A Po; M Silvano; E Miele; C Capalbo; A Eramo; V Salvati; M Todaro; Z M Besharat; G Catanzaro; D Cucchi; S Coni; L Di Marcotullio; G Canettieri; A Vacca; G Stassi; E De Smaele; M Tartaglia; I Screpanti; R De Maria; E Ferretti
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

Review 6.  Understanding cell signaling in cancer stem cells for targeted therapy - can phosphoproteomics help to reveal the secrets?

Authors:  Wolfgang Gruber; Tamara Scheidt; Fritz Aberger; Christian G Huber
Journal:  Cell Commun Signal       Date:  2017-03-29       Impact factor: 5.712

7.  MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs.

Authors:  Giuseppina Catanzaro; Zein Mersini Besharat; Neha Garg; Maurizio Ronci; Luisa Pieroni; Evelina Miele; Angela Mastronuzzi; Andrea Carai; Vincenzo Alfano; Agnese Po; Isabella Screpanti; Franco Locatelli; Andrea Urbani; Elisabetta Ferretti
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

8.  Top-down proteomic characterization of DAOY medulloblastoma tumor cell line.

Authors:  Claudia Martelli; Luca D'Angelo; Marta Barba; Mirko Baranzini; Ilaria Inserra; Federica Iavarone; Federica Vincenzoni; Gianpiero Tamburrini; Luca Massimi; Concezio Di Rocco; Massimo Caldarelli; Irene Messana; Fabrizio Michetti; Massimo Castagnola; Wanda Lattanzi; Claudia Desiderio
Journal:  EuPA Open Proteom       Date:  2016-04-01

9.  The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells.

Authors:  Evelina Miele; Sergio Valente; Vincenzo Alfano; Marianna Silvano; Paolo Mellini; Diana Borovika; Biagina Marrocco; Agnese Po; Zein Mersini Besharat; Giuseppina Catanzaro; Giuseppe Battaglia; Luana Abballe; Clemens Zwergel; Giulia Stazi; Ciro Milite; Sabrina Castellano; Marco Tafani; Peteris Trapencieris; Antonello Mai; Elisabetta Ferretti
Journal:  Oncotarget       Date:  2017-08-02

10.  Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells.

Authors:  Agnese Po; Anna Citarella; Giuseppina Catanzaro; Zein Mersini Besharat; Sofia Trocchianesi; Francesca Gianno; Claudia Sabato; Marta Moretti; Enrico De Smaele; Alessandra Vacca; Micol Eleonora Fiori; Elisabetta Ferretti
Journal:  Sci Rep       Date:  2020-08-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.